Fidelity has kick-started the price war in the index market again this month, and I applaud it for doing so. After all, why should an investor pay double digits for exposure to developed indices?
Thankfully Fidelity is not alone, and its competitors BlackRock, HSBC, L&G and Vanguard all offer cheap products in the same markets. The devil in the charges will be in the detail and there are clearly other issues to take into account when comparing the various products. Morningstar has produced some excellent research on index funds and how to analyse them, which I would suggest advisers look at when they are allocating. Why active vs passive is a false distinction From the Morningstar research, you learn that for an equivalent product, for which Fidelity is charging 6bps for ce...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
